DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY

Cash flow Dr. Sulaiman Al Habib Medical Services Group Company

Equities

4013

SA1510P1UMH1

Healthcare Facilities & Services

Market Closed - Saudi Arabian S.E. Other stock markets 05:50:01 04/06/2026 pm IST			5-day change	1st Jan Change
215.50 ^SAR	-1.19%		-1.06%	-16.15%

05/06	BSF Capital Lowers Dr. Sulaiman Al Habib Medical Services PT, Keeps at Hold	MT
02/06	Arqaam Capital Trims Dr. Sulaiman Al Habib Medical Services PT, Keeps Sell Rating	MT

571.Yg70czMVgGRZy7Syvf9NiaGSJUgWtBUEKQgTnUBddys.O0KrEFI4xlQ1idvf-NIspMLCYSdvxXZSTkVwwgcpQ14aZ8AYYHKxDTGv4Q

Published financial data: DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	725.05Cr	831.07Cr	950.84Cr	1.12TCr	1.37TCr
Total Revenues	725.05Cr	831.07Cr	950.84Cr	1.12TCr	1.37TCr
Cost of Goods Sold, Total	493.4Cr	557.81Cr	625.46Cr	747.07Cr	951.31Cr
Gross Profit	231.64Cr	273.27Cr	325.38Cr	372.97Cr	419.38Cr
Selling General & Admin Expenses, Total	85Cr	103.22Cr	115.82Cr	137.34Cr	157.48Cr
Other Operating Expenses, Total	85Cr	103.22Cr	115.82Cr	137.34Cr	157.48Cr
Operating Income	146.62Cr	170.05Cr	209.56Cr	235.63Cr	261.9Cr
Interest Expense, Total	-3.79Cr	-4.94Cr	-7.01Cr	-16Cr	-34Cr
Interest And Investment Income	99.03L	4.07Cr	8.21Cr	5.68Cr	5.27Cr
Net Interest Expenses	-2.8Cr	-86.38L	1.2Cr	-11Cr	-29Cr
Income (Loss) On Equity Invest.	74.89L	1.96Cr	2.22Cr	2.1Cr	2.27Cr
Other Non Operating Income (Expenses)	5.57Cr	8.52Cr	4.01Cr	9.79Cr	16Cr
EBT, Excl. Unusual Items	150.13Cr	179.67Cr	217Cr	236.92Cr	251.93Cr
Gain (Loss) On Sale Of Investments	-	-	-	4.37Cr	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
EBT, Incl. Unusual Items	150.13Cr	179.67Cr	217Cr	241.29Cr	251.93Cr
Income Tax Expense	11Cr	11Cr	6.85Cr	4.29Cr	2.76Cr
Earnings From Continuing Operations	138.73Cr	168.89Cr	210.15Cr	237Cr	249.17Cr
Net Income to Company	138.73Cr	168.89Cr	210.15Cr	237Cr	249.17Cr
Minority Interest	-1.07Cr	-3.82Cr	-5.55Cr	-5.47Cr	-9.02Cr
Net Income - (IS)	137.66Cr	165.08Cr	204.6Cr	231.53Cr	240.15Cr
Net Income to Common Incl Extra Items	137.66Cr	165.08Cr	204.6Cr	231.53Cr	240.15Cr
Net Income to Common Excl. Extra Items	137.66Cr	165.08Cr	204.6Cr	231.53Cr	240.15Cr
Per Share Items
Net EPS - Basic	3.93	4.72	5.85	6.62	6.86
Basic EPS - Continuing Operations	3.93	4.72	5.85	6.62	6.86
Basic Weighted Average Shares Outstanding	35Cr	35Cr	35Cr	35Cr	35Cr
Net EPS - Diluted	3.93	4.72	5.85	6.62	6.86
Diluted EPS - Continuing Operations	3.93	4.72	5.85	6.62	6.86
Diluted Weighted Average Shares Outstanding	35Cr	35Cr	35Cr	35Cr	35Cr
Normalized Basic EPS	2.65	3.1	3.72	4.07	4.24
Normalized Diluted EPS	2.65	3.1	3.72	4.07	4.24
Dividend Per Share	2.8	3.48	4.32	4.77	4.83
Payout Ratio	68.65	68.91	70.14	70.9	69.23
Supplemental Items
EBITDA	172.83Cr	196.03Cr	235.82Cr	271.1Cr	319.29Cr
EBITA	146.62Cr	170.05Cr	209.56Cr	235.63Cr	261.9Cr
EBIT	146.62Cr	170.05Cr	209.56Cr	235.63Cr	261.9Cr
EBITDAR	173.61Cr	197.04Cr	237.07Cr	273.6Cr	323.34Cr
Effective Tax Rate - (Ratio)	7.6	5.99	3.16	1.78	1.1
Normalized Net Income	93Cr	108.47Cr	130.08Cr	142.61Cr	148.44Cr
Interest on Long-Term Debt	3.79Cr	4.94Cr	7.01Cr	16Cr	34Cr
Non-Cash Pension Expense	1.22Cr	1.64Cr	2.51Cr	3.07Cr	-
Supplemental Operating Expense Items
Advertising Expense	2.28Cr	3.28Cr	3.57Cr	4.2Cr	7.31Cr
Selling and Marketing Expenses	24Cr	32Cr	40Cr	49Cr	42Cr
General and Administrative Expenses	60Cr	70Cr	74Cr	86Cr	111.07Cr
Net Rental Expense, Total	78.12L	1.01Cr	1.25Cr	2.5Cr	4.04Cr
Imputed Operating Lease Interest Expense	8L	12.16L	16.05L	48.75L	1.25Cr
Imputed Operating Lease Depreciation	69.79L	89.1L	1.09Cr	2.01Cr	2.79Cr
Maintenance & Repair Expenses, Total	1.38Cr	1.55Cr	1.62Cr	1.46Cr	1.32Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	264.38Cr	274.7Cr	262.04Cr	289.07Cr	228.16Cr
Total Cash And Short Term Investments	264.38Cr	274.7Cr	262.04Cr	289.07Cr	228.16Cr
Accounts Receivable, Total	90Cr	74Cr	70Cr	118.12Cr	167.89Cr
Total Receivables	90Cr	74Cr	70Cr	118.12Cr	167.89Cr
Inventory	41Cr	49Cr	54Cr	85Cr	102.83Cr
Prepaid Expenses	12Cr	11Cr	16Cr	21Cr	28Cr
Other Current Assets, Total	6.82Cr	7.21Cr	11Cr	19Cr	16Cr
Total Current Assets	413.34Cr	416.05Cr	413.78Cr	531.94Cr	542.73Cr
Gross Property Plant And Equipment	866.65Cr	1.02TCr	1.38TCr	1.78TCr	2.08TCr
Accumulated Depreciation	-201.39Cr	-229.23Cr	-258.9Cr	-298.21Cr	-352.39Cr
Net Property Plant And Equipment	665.26Cr	793.66Cr	1.12TCr	1.48TCr	1.73TCr
Long-term Investments	4.14Cr	49Cr	50Cr	47Cr	48Cr
Total Assets	1.08TCr	1.26TCr	1.58TCr	2.06TCr	2.32TCr
Liabilities
Accounts Payable, Total	76Cr	87Cr	101.56Cr	142.21Cr	169.31Cr
Accrued Expenses, Total	66Cr	117.89Cr	161.32Cr	192.99Cr	228.03Cr
Current Portion of Long-Term Debt	32Cr	17Cr	9.6Cr	9.6Cr	9.6Cr
Current Portion of Leases	3.92Cr	4.41Cr	4.18Cr	7.43Cr	10Cr
Current Income Taxes Payable	13Cr	17Cr	18Cr	15Cr	9.57Cr
Unearned Revenue Current, Total	3.85Cr	4.11Cr	8.55Cr	6.71Cr	12Cr
Other Current Liabilities	11Cr	12Cr	27Cr	42Cr	33Cr
Total Current Liabilities	204.77Cr	259.03Cr	329.92Cr	416.18Cr	471.87Cr
Long-Term Debt	244.49Cr	303.26Cr	481.03Cr	766.19Cr	873.46Cr
Long-Term Leases	25Cr	28Cr	24Cr	33Cr	37Cr
Unearned Revenue Non Current	6.59Cr	6.03Cr	5.46Cr	4.9Cr	4.37Cr
Pension & Other Post Retirement Benefits	49Cr	52Cr	63Cr	74Cr	91Cr
Total Liabilities	530.03Cr	647.85Cr	903.18Cr	1.29TCr	1.48TCr
Common Stock, Total	350Cr	350Cr	350Cr	350Cr	350Cr
Retained Earnings	183.92Cr	237.87Cr	298.55Cr	367.51Cr	440.17Cr
Total Common Equity	533.92Cr	587.87Cr	648.55Cr	717.51Cr	790.17Cr
Minority Interest	19Cr	23Cr	28Cr	44Cr	53Cr
Total Equity	552.71Cr	610.57Cr	676.62Cr	761.26Cr	842.87Cr
Total Liabilities And Equity	1.08TCr	1.26TCr	1.58TCr	2.06TCr	2.32TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	35Cr	35Cr	35Cr	35Cr	35Cr
ECS Total Common Shares Outstanding	35Cr	35Cr	35Cr	35Cr	35Cr
Book Value / Share	15.25	16.8	18.53	20.5	22.58
Tangible Book Value	533.92Cr	587.87Cr	648.55Cr	717.51Cr	790.17Cr
Tangible Book Value Per Share	15.25	16.8	18.53	20.5	22.58
Total Debt	305.44Cr	352.15Cr	518.34Cr	816.55Cr	930.46Cr
Net Debt	41Cr	77Cr	256.3Cr	527.48Cr	702.3Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	49Cr	52Cr	63Cr	74Cr	-
Debt Equivalent Oper. Leases	6.25Cr	8.1Cr	9.97Cr	20Cr	32Cr
Minority Interest, Total (Incl. Fin. Div)	19Cr	23Cr	28Cr	44Cr	53Cr
Equity Method Investments, Total	4.14Cr	19Cr	20Cr	17Cr	18Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	-	-	-	-	-
Inventories - Others	41Cr	51Cr	57Cr	88Cr	105.48Cr
Land - (BS)	256.26Cr	283.83Cr	619.12Cr	1.07TCr	1.47TCr
Buildings, Total	274.71Cr	276.39Cr	-	-	-
Machinery, Total	195.97Cr	211.01Cr	232.45Cr	334.92Cr	450.23Cr
Full Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	18Cr	28Cr	40Cr	34Cr	9.82Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	137.66Cr	165.08Cr	204.6Cr	231.53Cr	240.15Cr
Depreciation & Amortization - CF	31Cr	31Cr	31Cr	42Cr	67Cr
Depreciation & Amortization, Total	31Cr	31Cr	31Cr	42Cr	67Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-74.89L	-1.96Cr	-2.22Cr	-2.1Cr	-2.27Cr
Provision and Write-off of Bad Debts	15Cr	20Cr	-	-	-
Other Operating Activities, Total	20Cr	18Cr	48Cr	60Cr	67Cr
Change In Accounts Receivable	-20Cr	-4.03Cr	-20Cr	-69Cr	-65Cr
Change In Inventories	-3.45Cr	-8.35Cr	-5.82Cr	-31Cr	-18Cr
Change In Accounts Payable	18Cr	16Cr	33Cr	56Cr	18Cr
Change in Unearned Revenues	-41.23L	-	-	-	-
Change in Other Net Operating Assets	21Cr	49Cr	36Cr	9.61Cr	34Cr
Cash from Operations	218.28Cr	284.37Cr	324.42Cr	297.04Cr	340.19Cr
Capital Expenditure	-125.35Cr	-151.34Cr	-349.69Cr	-382.86Cr	-298.33Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Real Estate properties	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-43Cr	-25.5L	4.1Cr	-33L
Other Investing Activities, Total	60L	-	1.28Cr	1.22Cr	1.61Cr
Cash from Investing	-124.75Cr	-193.94Cr	-348.66Cr	-377.54Cr	-297.04Cr
Long-Term Debt Issued, Total	40Cr	43Cr	170.05Cr	300.42Cr	122.53Cr
Total Debt Issued	40Cr	43Cr	170.05Cr	300.42Cr	122.53Cr
Long-Term Debt Repaid, Total	-4.51Cr	-5.27Cr	-8.57Cr	-23Cr	-27Cr
Total Debt Repaid	-4.51Cr	-5.27Cr	-8.57Cr	-23Cr	-27Cr
Common Dividends Paid	-94Cr	-113.75Cr	-143.5Cr	-164.15Cr	-166.25Cr
Common & Preferred Stock Dividends Paid	-94Cr	-113.75Cr	-143.5Cr	-164.15Cr	-166.25Cr
Other Financing Activities, Total	-3.66Cr	-4.33Cr	-6.4Cr	-5.66Cr	-33Cr
Cash from Financing	-63Cr	-80Cr	12Cr	107.53Cr	-104.05Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	30Cr	10Cr	-13Cr	27Cr	-61Cr
Supplemental Items
Cash Interest Paid	3.66Cr	4.33Cr	6.4Cr	16Cr	33Cr
Levered Free Cash Flow	28Cr	59Cr	-123.95Cr	-211.8Cr	-107.26Cr
Unlevered Free Cash Flow	31Cr	62Cr	-119.56Cr	-201.62Cr	-86Cr
Change In Net Working Capital	-33Cr	-76Cr	-68Cr	8.11Cr	19Cr
Net Debt Issued / Repaid	35Cr	38Cr	161.49Cr	277.34Cr	96Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.02	9.08	9.23	8.1	7.48
Return on Total Capital	11.24	11.67	12.14	10.62	9.77
Return On Equity %	26.14	29.04	32.65	32.96	31.07
Return on Common Equity	26.86	29.43	33.1	33.9	31.86
Margin Analysis
Gross Profit Margin %	31.95	32.88	34.22	33.3	30.6
SG&A Margin	11.73	12.42	12.18	12.26	11.49
EBITDA Margin %	23.84	23.59	24.8	24.2	23.29
EBITA Margin %	20.22	20.46	22.04	21.04	19.11
EBIT Margin %	20.22	20.46	22.04	21.04	19.11
Income From Continuing Operations Margin %	19.13	20.32	22.1	21.16	18.18
Net Income Margin %	18.99	19.86	21.52	20.67	17.52
Net Avail. For Common Margin %	18.99	19.86	21.52	20.67	17.52
Normalized Net Income Margin	12.79	13.05	13.68	12.73	10.83
Levered Free Cash Flow Margin	3.92	7.12	-13.04	-18.91	-7.83
Unlevered Free Cash Flow Margin	4.24	7.49	-12.57	-18	-6.28
Asset Turnover
Asset Turnover	0.71	0.71	0.67	0.62	0.63
Fixed Assets Turnover	1.18	1.14	1	0.86	0.85
Receivables Turnover (Average Receivables)	8.32	10.13	13.16	11.82	9.58
Inventory Turnover (Average Inventory)	12.54	12.43	12.1	10.75	10.15
Short Term Liquidity
Current Ratio	2.02	1.61	1.25	1.28	1.15
Quick Ratio	1.73	1.35	1.01	0.98	0.84
Operating Cash Flow to Current Liabilities	1.07	1.1	0.98	0.71	0.72
Days Sales Outstanding (Average Receivables)	43.89	36.03	27.73	30.97	38.08
Days Outstanding Inventory (Average Inventory)	29.1	29.36	30.15	34.05	35.97
Average Days Payable Outstanding	50.01	52.61	54.65	57.38	58.64
Cash Conversion Cycle (Average Days)	22.98	12.79	3.24	7.64	15.41
Long Term Solvency
Total Debt/Equity	55.26	57.68	76.61	107.26	110.39
Total Debt / Total Capital	35.59	36.58	43.38	51.75	52.47
LT Debt/Equity	48.81	54.21	74.57	105.02	108.06
Long-Term Debt / Total Capital	31.43	34.38	42.22	50.67	51.36
Total Liabilities / Total Assets	48.95	51.48	57.17	62.97	63.68
EBIT / Interest Expense	38.69	34.45	29.89	14.48	7.73
EBITDA / Interest Expense	47	40.72	34.35	17.06	9.71
(EBITDA - Capex) / Interest Expense	13.92	10.06	-15.53	-6.46	0.91
Total Debt / EBITDA	1.72	1.75	2.15	2.94	2.83
Net Debt / EBITDA	0.23	0.39	1.06	1.9	2.13
Total Debt / (EBITDA - Capex)	5.79	7.09	-4.76	-7.77	30.27
Net Debt / (EBITDA - Capex)	0.78	1.56	-2.35	-5.02	22.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.69	14.62	14.41	17.79	22.38
Gross Profit, 1 Yr. Growth %	25.02	17.97	19.07	14.63	12.44
EBITDA, 1 Yr. Growth %	25.41	13.42	20.3	14.96	17.78
EBITA, 1 Yr. Growth %	31.51	15.98	23.24	12.44	11.15
EBIT, 1 Yr. Growth %	31.51	15.98	23.24	12.44	11.15
Earnings From Cont. Operations, 1 Yr. Growth %	34.03	21.75	24.42	12.78	5.14
Net Income, 1 Yr. Growth %	30.43	19.91	23.94	13.16	3.72
Normalized Net Income, 1 Yr. Growth %	27.89	16.93	19.92	9.63	4.09
Diluted EPS Before Extra, 1 Yr. Growth %	30.43	19.91	23.94	13.16	3.72
Accounts Receivable, 1 Yr. Growth %	6.51	-17.52	-5.2	65.35	42.13
Inventory, 1 Yr. Growth %	7.1	20.52	10.74	55.95	21.42
Net Property, Plant and Equip., 1 Yr. Growth %	17.79	19.3	40.65	32.34	17.12
Total Assets, 1 Yr. Growth %	14.2	16.22	25.54	30.13	12.88
Tangible Book Value, 1 Yr. Growth %	8.7	10.1	10.32	10.63	10.13
Common Equity, 1 Yr. Growth %	8.7	10.1	10.32	10.63	10.13
Cash From Operations, 1 Yr. Growth %	-2.3	30.28	14.08	-8.44	14.53
Capital Expenditures, 1 Yr. Growth %	54	20.73	131.07	9.49	-22.08
Levered Free Cash Flow, 1 Yr. Growth %	-69.27	108.38	-309.51	70.88	-49.36
Unlevered Free Cash Flow, 1 Yr. Growth %	-67.77	102.36	-292.09	68.63	-57.3
Dividend Per Share, 1 Yr. Growth %	33.33	24.29	24.14	10.42	1.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	20.22	19.07	14.52	16.09	20.06
Gross Profit, 2 Yr. CAGR %	23.67	21.45	18.52	16.83	13.53
EBITDA, 2 Yr. CAGR %	26.87	19.27	16.81	17.6	16.36
EBITA, 2 Yr. CAGR %	29.99	23.5	19.56	17.71	11.79
EBIT, 2 Yr. CAGR %	29.99	23.5	19.56	17.71	11.79
Earnings From Cont. Operations, 2 Yr. CAGR %	28.7	27.74	23.08	18.46	8.89
Net Income, 2 Yr. CAGR %	25.77	25.06	21.91	18.43	8.34
Normalized Net Income, 2 Yr. CAGR %	24.64	22.29	18.41	14.66	6.82
Diluted EPS Before Extra, 2 Yr. CAGR %	25.77	25.06	21.91	18.43	8.34
Accounts Receivable, 2 Yr. CAGR %	-22.76	-6.27	-11.58	26.2	53.3
Inventory, 2 Yr. CAGR %	17.27	13.61	15.53	31.41	37.61
Net Property, Plant and Equip., 2 Yr. CAGR %	13.74	18.54	29.54	36.43	24.5
Total Assets, 2 Yr. CAGR %	13.08	15.21	20.79	27.81	21.2
Tangible Book Value, 2 Yr. CAGR %	10.23	9.4	10.21	10.48	10.38
Common Equity, 2 Yr. CAGR %	10.23	9.4	10.21	10.48	10.38
Cash From Operations, 2 Yr. CAGR %	43.56	12.82	21.91	2.2	2.4
Capital Expenditures, 2 Yr. CAGR %	30.78	36.35	67.02	59.06	-7.64
Levered Free Cash Flow, 2 Yr. CAGR %	48.59	-19.98	108.95	89.21	-6.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	66.38	-19.24	97.16	79.98	-15.15
Dividend Per Share, 2 Yr. CAGR %	-	28.73	24.21	17.08	5.74
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.48	18.33	17.5	15.6	18.15
Gross Profit, 3 Yr. CAGR %	19.63	21.74	20.65	17.21	15.35
EBITDA, 3 Yr. CAGR %	19.94	22.22	19.61	16.19	17.66
EBITA, 3 Yr. CAGR %	22.3	25.14	23.41	17.13	15.48
EBIT, 3 Yr. CAGR %	22.3	25.14	23.41	17.13	15.48
Earnings From Cont. Operations, 3 Yr. CAGR %	20.14	26.34	26.63	19.54	13.84
Net Income, 3 Yr. CAGR %	19.77	23.79	24.69	18.92	13.31
Normalized Net Income, 3 Yr. CAGR %	18.86	22.01	21.49	15.41	11.02
Diluted EPS Before Extra, 3 Yr. CAGR %	19.77	23.79	24.69	18.92	13.31
Accounts Receivable, 3 Yr. CAGR %	-11.81	-21.05	-5.92	9.52	31.3
Inventory, 3 Yr. CAGR %	10.38	18.34	12.65	27.68	27.99
Net Property, Plant and Equip., 3 Yr. CAGR %	15.77	15.57	25.49	30.47	29.67
Total Assets, 3 Yr. CAGR %	12.81	14.12	18.55	23.83	22.63
Tangible Book Value, 3 Yr. CAGR %	7.25	10.19	9.71	10.35	10.36
Common Equity, 3 Yr. CAGR %	7.25	10.19	9.71	10.35	10.36
Cash From Operations, 3 Yr. CAGR %	14.68	38.99	13.24	10.82	6.16
Capital Expenditures, 3 Yr. CAGR %	23.96	27.34	62.56	45.09	25.39
Levered Free Cash Flow, 3 Yr. CAGR %	-16.04	66.32	10.29	95.4	21.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	-14.48	77.6	7.81	87.15	11.41
Dividend Per Share, 3 Yr. CAGR %	-	-	27.18	19.43	11.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.29	12.14	15.69	17.43	18.52
Gross Profit, 5 Yr. CAGR %	4.25	12.14	19.19	19.75	17.75
EBITDA, 5 Yr. CAGR %	9.77	18.54	18.68	20.35	18.3
EBITA, 5 Yr. CAGR %	9.71	21.69	21.19	22.11	18.63
EBIT, 5 Yr. CAGR %	9.71	21.69	21.19	22.11	18.63
Earnings From Cont. Operations, 5 Yr. CAGR %	6.56	20.74	21.3	23.12	19.21
Net Income, 5 Yr. CAGR %	6.39	20.18	20.62	21.62	17.87
Normalized Net Income, 5 Yr. CAGR %	7.2	18.92	18.68	19.02	15.4
Diluted EPS Before Extra, 5 Yr. CAGR %	6.39	20.18	20.62	21.62	17.87
Accounts Receivable, 5 Yr. CAGR %	-14.24	-15.16	-11.72	-4.76	14.74
Inventory, 5 Yr. CAGR %	9.26	9.71	12.41	23.41	22.04
Net Property, Plant and Equip., 5 Yr. CAGR %	14.01	16.79	21.09	23.5	25.1
Total Assets, 5 Yr. CAGR %	9.99	12.41	15.94	19.41	19.6
Tangible Book Value, 5 Yr. CAGR %	4.55	6.29	8.43	10.31	9.98
Common Equity, 5 Yr. CAGR %	4.55	6.29	8.43	10.31	9.98
Cash From Operations, 5 Yr. CAGR %	19.39	21.86	17.52	22.91	8.77
Capital Expenditures, 5 Yr. CAGR %	0.18	30.24	39.66	39.19	29.66
Levered Free Cash Flow, 5 Yr. CAGR %	-15.26	6.15	20.91	75.12	3.03
Unlevered Free Cash Flow, 5 Yr. CAGR %	-13.86	6.65	19.45	78.55	-2.04
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	18.13